Progressive lung disease caused by ABCA3 mutation

T. Sismanlar Eyuboglu (Ankara, Turkey), T. Ramasli Gursoy (Ankara, Turkey), A. Aslan (Ankara, Turkey), Z. Onay (Ankara, Turkey), S. Pekcan (Ankara, Turkey), M. Griese (Munich, Germany)

Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance
Session: From the bronchoscope to the clinic: paediatric bronchology at a glance
Session type: E-poster session
Number: 3527
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Sismanlar Eyuboglu (Ankara, Turkey), T. Ramasli Gursoy (Ankara, Turkey), A. Aslan (Ankara, Turkey), Z. Onay (Ankara, Turkey), S. Pekcan (Ankara, Turkey), M. Griese (Munich, Germany). Progressive lung disease caused by ABCA3 mutation. 3527

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010


Pediatric interstitial lung disease caused by a novel ABCA3 mutation: ABCA3G964A
Source: Annual Congress 2009 - Cell biology of lung disease
Year: 2009


Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations
Source: Eur Respir J 2014; 43: 638-641
Year: 2013


Classification of different ABCA3 mutations causing interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015


Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis
Source: Eur Respir J 2015; 46: 474-485
Year: 2015



Lung disease caused by non-null ABCA3 mutations: long-term follow-up
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018

Mutations in SFTPC, SFTPA2 and TERT explain 60% of familial pulmonary fibrosis and correlate to specific disease phenotypes
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011

Intersitial lung disease in chlidren with mutation in the  SFTPC and SFPTB gene: A two case report
Source: International Congress 2017 – Pulmonary infection and inflammation
Year: 2017

Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations
Source: Eur Respir J 2011; 37: 201-204
Year: 2011


Interstitial lung disease in a child heterozygous for the 1549C?GAA (121ins2) mutation of surfactant protein B
Source: Eur Respir J 2011; 38: 985-987
Year: 2011


Bi-allelic missense ABCA3 mutations in a patient with childhood ILD who reached adulthood
Source: ERJ Open Res, 5 (3) 00066-2019; 10.1183/23120541.00066-2019
Year: 2019



Sftpc mutations are a common cause of adult familial idiopathic interstitial pneumonia
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009


SP-C deficiency: Three different phenotypes for the same mutation
Source: International Congress 2015 – Paediatric bronchology
Year: 2015

Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His
Source: ERJ Open Res, 3 (1) 00056-2016; 10.1183/23120541.00056-2016
Year: 2017



Diffuse lung disease and pulmonary hypertension related to TBX4 mutation in 5 children
Source: International Congress 2019 – A mixture of rare lung diseases
Year: 2019

A novel non-BRICHOS surfactant protein C mutation causing infantile interstitial lung disease is associated with reduced mature SP-C level
Source: International Congress 2018 – Orphan diseases in children
Year: 2018


First heterozygous NOP10 mutation in familial pulmonary fibrosis
Source: Eur Respir J, 55 (6) 1902465; 10.1183/13993003.02465-2019
Year: 2020



Progressive fibrosis is common in patients with Sjögren’s syndrome and Interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Homozygous mutations of ARFGAP1 gene in severe sarcoidosis
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


SFTPA mutations in interstitial lung disease (ILD) and lung cancer
Source: International Congress 2017 – Rare diseases
Year: 2017